seladelpar
seladelpar: sourced relationships with 1 company · 2 clinical trials tracked.
seladelpar evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could seladelpar → CBAY affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| CymaBay Therapeutics, Inc. (CBAY) | Phase 2 |
Clinical Trial Registry Records (2)
A Phase 2 Proof-of-Concept Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Active Treatment Extension Period to Assess the Safety and Efficacy of Seladelpar and Cilofexor in Combination for Primary Biliary Cholangitis
Primary endpoint: Change From Baseline in Serum Concentration of Alkaline Phosphate (ALP) at Week 24
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary endpoint: Event Free Survival (EFS)
Frequently asked questions
Which companies have sourced relationships with seladelpar?
seladelpar has dated SEC/FDA relationship records for CymaBay Therapeutics, Inc..
How many clinical trials involve seladelpar?
BioSniper tracks 2 clinical trials involving seladelpar.